Financials

  • Market Capitalization 163.98 M
  • Employee 152
  • Founded 2013
  • CEO N/A
  • Website www.lenz-tx.com
  • Headquarter Delaware, United States
  • FIGI BBG00XDH4NZ2
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-5.61
Rapporto prezzo/fatturato
24.15

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3736
ALEC
Alector, Inc. - Common Stock
1.51 USD-6.21%-23.35%-3.21%-10.65%167.65 M USD
3738
CRBP
Corbus Pharmaceuticals Holdings, Inc. - Common Stock
9.04 USD-6.61%-0.55%+8.78%-45.54%167.49 M USD
3751
ANTX
AN2 Therapeutics, Inc. - Common Stock
4.55 USD+1.11%+2.94%-4.01%+321.30%163.87 M USD
3756
CBUS
Cibus, Inc. - Class A Common Stock
2.13 USD+5.45%+48.95%+67.72%+39.22%162.59 M USD